{"id":470407,"date":"2021-04-02T16:18:15","date_gmt":"2021-04-02T20:18:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=470407"},"modified":"2021-04-02T16:18:15","modified_gmt":"2021-04-02T20:18:15","slug":"proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/","title":{"rendered":"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p>LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., April  02, 2021  (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics N.V.\u00a0(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual presentation at the Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) held April 9-11, 2021.<\/p>\n<p>\n        <b><br \/>\n          <strong>ProQR\u2019s presentation<\/strong><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <strong>Presentation title:<\/strong>\u00a0A different type of genetic therapy: correcting a defective gene using antisense oligonucleotide treatment in <em>CEP290<\/em> p.Cys998X LCA<br \/><strong>Presenter:<\/strong>\u00a0Arlene V. Drack, MD, Ronald Keech Professor of Pediatric Genetic Eye Disease Department of Ophthalmology and Visual Sciences, University of Iowa<br \/><strong>Presentation type: <\/strong>Oral paper presentation<br \/><strong>Date:<\/strong>\u00a0April 10, 2021 at 1:23pm EDT. The presentation will be available for viewing until July 15, 2021.<\/p>\n<p>\n        <b>About Leber Congenital Amaurosis 10 (LCA10)<\/b>\n      <\/p>\n<p>Leber congenital amaurosis (LCA) is the most common cause of blindness due to genetic disease in children. It consists of a group of diseases of which LCA10 is the most frequent and one of the most severe forms. LCA10 is caused by mutations in the CEP290 gene, of which the p.Cys998X mutation has the highest prevalence. LCA10 leads to early loss of vision causing most people to lose their sight in the first few years of life. To date, there are no treatments approved that treat the underlying cause of the disease. Approximately 2,000 people in the Western world have LCA10 because of this mutation.<\/p>\n<p>\n        <b>About Sepofarsen<\/b><br \/>\n        <br \/> Sepofarsen (QR-110) is being evaluated in the pivotal Phase 2\/3\u00a0Illuminate\u00a0trial and is a first-in-class investigational RNA therapy designed to address the underlying cause of Leber congenital amaurosis 10 due to the p.Cys998X mutation (also known as the c.2991+1655A&gt;G mutation) in the\u00a0CEP290\u00a0gene. The p.Cys998X mutation leads to aberrant splicing of the mRNA and non-functional CEP290 protein. Sepofarsen is designed to enable normal splicing, resulting in restoration of normal (wild type) CEP290 mRNA and subsequent production of functional CEP290 protein. Sepofarsen is intended to be administered through intravitreal injections in the eye and has been granted orphan drug designation in the United States and the European Union and received fast-track designation and rare pediatric disease designation from the FDA as well as access to the PRIME scheme by the EMA.<\/p>\n<p>\n        <b>About ProQR<\/b>\n      <\/p>\n<p>ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.<br \/>Learn more about ProQR at <strong><b><u>www.proqr.com<\/u><\/b><\/strong>.<\/p>\n<p>\n        <b>Forward Looking Statements<\/b>\n      <\/p>\n<p>This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;look forward to&#8221;, &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions. Such forward-looking statements include those relating to our presentation at AAPOS. Forward-looking statements are based on management&#8217;s beliefs and assumptions and on information available to management only as of the date of this press release. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors in our filings made with the Securities and Exchange Commission, including certain sections of our annual report filed on Form 20-F. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future, except as required by law.<\/p>\n<p>\n        <b>ProQR Therapeutics N.V.<\/b>\n      <\/p>\n<p>\n        <b>Investor Contact:<\/b><br \/>\n        <br \/> Sarah Kiely<br \/> ProQR Therapeutics N.V.<br \/> T: +1 617 599 6228<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6kiYPAbZ1E5Kr71yIplRp2VI-yWTuZI2Gy2Yaxthnq1COmwqz0EceP6o2x0CufW-VYklq5lw3eoNa99ZqDwHaA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><b><u>skiely@proqr.com<\/u><\/b><\/strong><\/a><br \/> or<br \/> Hans Vitzthum<br \/> LifeSci Advisors<br \/> T: +1 617 430 7578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mDPGLXCNoIexbOGMON21cSTPO4YyNxeusQiRpahHwe8P3uTSnmgM74YLCNaor_krVASBtouz4nqfalSLdM91NHxdl5bFyQMj6TFynnG8yQ8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><b><u>hans@lifesciadvisors.com<\/u><\/b><\/strong><\/a><\/p>\n<p>\n        <b>Media Contact:<\/b><br \/>\n        <br \/> Cherilyn Cecchini, MD<br \/> LifeSci Communications<br \/> T: +1 646 876 5196<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Hd1_gohKoKw-5Ish8GnaQG6kzKLeHk5wp-kdF0di-__kjClUPVFPEFkLlDh5_4ZJLrZ1x1naDXLrAc2-3AT7rRTX35ZuXwnstYzZxNci_qbg8ti3YgHibZF2RAuaT7kG\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><b><u>ccecchini@lifescicomms.com<\/u><\/b><\/strong><\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/d204fe50-792c-4422-86fb-d13a42ebbafb\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., April 02, 2021 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics N.V.\u00a0(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual presentation at the Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) held April 9-11, 2021. ProQR\u2019s presentation Presentation title:\u00a0A different type of genetic therapy: correcting a defective gene using antisense oligonucleotide treatment in CEP290 p.Cys998X LCAPresenter:\u00a0Arlene V. Drack, MD, Ronald Keech Professor of Pediatric Genetic Eye Disease Department of Ophthalmology and Visual Sciences, University of IowaPresentation type: Oral paper presentationDate:\u00a0April 10, 2021 at 1:23pm EDT. The presentation will be available for viewing until July 15, 2021. About Leber Congenital Amaurosis &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-470407","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., April 02, 2021 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics N.V.\u00a0(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual presentation at the Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) held April 9-11, 2021. ProQR\u2019s presentation Presentation title:\u00a0A different type of genetic therapy: correcting a defective gene using antisense oligonucleotide treatment in CEP290 p.Cys998X LCAPresenter:\u00a0Arlene V. Drack, MD, Ronald Keech Professor of Pediatric Genetic Eye Disease Department of Ophthalmology and Visual Sciences, University of IowaPresentation type: Oral paper presentationDate:\u00a0April 10, 2021 at 1:23pm EDT. The presentation will be available for viewing until July 15, 2021. About Leber Congenital Amaurosis &hellip; Continue reading &quot;ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-02T20:18:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021\",\"datePublished\":\"2021-04-02T20:18:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/\"},\"wordCount\":654,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/\",\"name\":\"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==\",\"datePublished\":\"2021-04-02T20:18:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/","og_locale":"en_US","og_type":"article","og_title":"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 - Market Newsdesk","og_description":"LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., April 02, 2021 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics N.V.\u00a0(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual presentation at the Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) held April 9-11, 2021. ProQR\u2019s presentation Presentation title:\u00a0A different type of genetic therapy: correcting a defective gene using antisense oligonucleotide treatment in CEP290 p.Cys998X LCAPresenter:\u00a0Arlene V. Drack, MD, Ronald Keech Professor of Pediatric Genetic Eye Disease Department of Ophthalmology and Visual Sciences, University of IowaPresentation type: Oral paper presentationDate:\u00a0April 10, 2021 at 1:23pm EDT. The presentation will be available for viewing until July 15, 2021. About Leber Congenital Amaurosis &hellip; Continue reading \"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-02T20:18:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021","datePublished":"2021-04-02T20:18:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/"},"wordCount":654,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/","name":"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==","datePublished":"2021-04-02T20:18:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3NjM2MSM0MDA5MDU3MTAjMjAxMTE2Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-virtual-presentation-at-american-association-for-pediatric-ophthalmology-and-strabismus-aapos-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=470407"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470407\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=470407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=470407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=470407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}